Patients for Patient Safety US to Celebrate New Patient Safety Rules on World Patient Safety Day

WASHINGTON, DC / ACCESSWIRE / August 8, 2024 / As World Patient Safety Day 2024 approaches on September 17th, Patients for Patient Safety US (PFPS US) commends the U.S. Centers for Medicare and Medicaid Services (CMS) for adding a game-changing new Patient Safety Structural Measure (PSSM) to the payment and policy rules for hospitals providing services under Medicare, Medicaid and the Children’s Health Insurance Program.

Starting on October 1, 2024, the PSSM asks hospital leaders to attest to whether their hospital uses recognized best practices to ensure patient safety. The attestation statements are structured under five domains: 1) Leadership Commitment to Eliminating Preventable Harm, 2) Strategic Planning & Organizational Policy, 3) Culture of Safety & Learning Systems, 4) Accountability & Transparency, and 5) Patient & Family Engagement. When fully implemented, hospital-specific results will be publicly reported by CMS, reinforcing public confidence in hospital safety and informing patient choice.

“These best practices aren’t new, but patients don’t know which ones are and which ones are not in place in the hospitals we use,” said Beth Daley Ullem, a co-founder of PFPS US. “CMS, the Joint Commission, and State licensing bodies do not know either. It’s astounding that 25 years after the To Err is Human report’s call to action, so much patient safety performance information is still hidden.”

Carole Hemmelgarn, PFPS US co-founder, added, “Inclusion of the PSSM in the Medicare Program exemplifies federal leadership on patient safety. This is a great step forward for transparency.”

In 2022, PFPS US published “Who Killed Patient Safety?” to reignite the prioritization of patient safety as a public health issue, which led to significant strides. U.S. Department of Health and Human Services Secretary Xavier Becerra established the National Action Alliance for Healthcare and Workforce Safety, CMS set a goal of “zero preventable harm,” new federal rules have strengthened patient access to medical records, and President Biden’s prestigious Presidential Council of Advisors on Science and Technology issued transformational patient safety recommendations.

“We’ll celebrate these important steps on World Patient Safety Day, and encourage our leaders to continue this urgent work,” said Sue Sheridan, co-founder of PFPS US. Established by the World Health Organization, World Patient Safety Day 2024 kicks off a year of focus on Improving Diagnostic Safety. PFPS US is planning several activities in Washington, DC, from September 15-17th to recognize loved ones lost to or harmed by unsafe care and call for further action. “We must shine a light on the preventable harm related to missed, delayed or failure to communicate diagnoses, which contributes to the harm or death of up to 795,000 Americans annually,” added Sheridan.

About Patients for Patient Safety US (PFPS US) (www.pfps.us)
As part of the World Health Organization’s global Patients for Patient Safety initiative, PFPS US is a patient-led nonprofit based in the United States. We are dedicated to enhancing healthcare through transparency, accountability, and active engagement of patients and families.

Media Contact: Sue Sheridan, ssheridan@pfps.us

Contact Information
Martin Hatlie
Founding Member / Executive Leadership
mhatlie@pfps.us
312-543-5658

Sue Sheridan
Founding Member / Executive Leadership
ssheridan@pfps.us
208-867-3479

Armando Nahum
Founding Member / Executive Leadership
anahum@pfps.us
404-510-8787

SOURCE: Patients for Patient Safety US

View the original press release on newswire.com.

Staff

Recent Posts

Vrtly Introduces Vrtly Ad Manager: Revolutionizing Digital Content Distribution for Brands

SAN RAMON, Calif., Aug. 10, 2024 /PRNewswire/ -- Vrtly, the leading Point-of-Care (POC) ad platform for…

1 day ago

MAPS Statement on FDA Complete Response Letter for MDMA-Assisted Therapy for PTSD New Drug Application

MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe…

1 day ago

PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002

TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

1 day ago

Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights

Advancement of clinical and regulatory steps enable the expected initiation of Phase 2 obesity clinical…

1 day ago

ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update

KEY HIGHLIGHTS Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic…

1 day ago

Acorn Credentialing to Showcase Cutting-Edge Credentialing Solution at NACDS Event

DELRAY BEACH, Fla., Aug. 9, 2024 /PRNewswire/ -- Acorn Credentialing, a leading provider of automated…

2 days ago